Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.

By B. Coiffier, A. Altman, Ching-Hon Pui, A. Younes, M. Cairo. Journal of Clinical Oncology, 2008

697 citations recorded by the source corpus.

Subfields: Molecular Biology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/34941b83f367cfc14bd606f61ec4af43e1cacf5f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. George
2. T. Singer
3. J. Mitchell
4. P. Treuting
5. H. Kropshofer
6. T. Albertson
7. T. Hansel
8. B. Preston

Citations in the corpus

• Case Series (2010, background): “Clinically significant ATLS, with end-organ compromise, occurs in approximately 5% of all patients with hematologic malignancies (Hochberg and Cairo 2008) and in up to 25% of highrisk patients, including those with T-cell acute lymphoblastic leukemia and Burkitt’s lymphoma (Coiffier et al. 2008).”
• The safety and side effects of monoclonal antibodies (2010, background): “TLS is a potentially life-threatening complication that can occur early with mAb therapy for neoplastic conditions, although this lysis is related to the desired effect of the agen”